158 related articles for article (PubMed ID: 30953615)
1. Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90.
Yu Z; Jv Y; Cai L; Tian X; Huo X; Wang C; Zhang B; Sun C; Ning J; Feng L; Zhang H; Ma X
Toxicol Appl Pharmacol; 2019 May; 371():63-73. PubMed ID: 30953615
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
[TBL] [Abstract][Full Text] [Related]
3. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
[TBL] [Abstract][Full Text] [Related]
4. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
6. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
Xiu AY; Ding Q; Li Z; Zhang CQ
Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
[TBL] [Abstract][Full Text] [Related]
7. Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.
Song YN; Zhang GB; Lu YY; Chen QL; Yang L; Wang ZT; Liu P; Su SB
J Ethnopharmacol; 2016 Aug; 189():148-56. PubMed ID: 27196295
[TBL] [Abstract][Full Text] [Related]
8. Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling.
MadanKumar P; NaveenKumar P; Manikandan S; Devaraj H; NiranjaliDevaraj S
Toxicol Appl Pharmacol; 2014 Jun; 277(2):210-20. PubMed ID: 24657339
[TBL] [Abstract][Full Text] [Related]
9. Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways.
Zhang F; Zhang Z; Kong D; Zhang X; Chen L; Zhu X; Lu Y; Zheng S
Mol Cell Endocrinol; 2014 Jan; 382(1):197-204. PubMed ID: 24071517
[TBL] [Abstract][Full Text] [Related]
10. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway.
Ding Q; Li Z; Liu B; Ling L; Tian X; Zhang C
Hum Pathol; 2018 Jun; 76():37-46. PubMed ID: 29514109
[TBL] [Abstract][Full Text] [Related]
11. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
[TBL] [Abstract][Full Text] [Related]
12. Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS.
Huang Y; Li Y; Lou A; Wang GZ; Hu Y; Zhang Y; Huang W; Wang J; Li Y; Zhu X; Chen T; Lin J; Meng Y; Li X
Clin Sci (Lond); 2020 Apr; 134(7):853-869. PubMed ID: 32227122
[TBL] [Abstract][Full Text] [Related]
13. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
15. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
16. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2.
Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY
World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625
[TBL] [Abstract][Full Text] [Related]
18. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis.
Kim BH; Yoon JH; Yang JI; Myung SJ; Lee JH; Jung EU; Yu SJ; Kim YJ; Lee HS; Kim CY
J Gastroenterol Hepatol; 2013 Dec; 28(12):1859-68. PubMed ID: 23808824
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway.
Chen Q; Chen L; Wu X; Zhang F; Jin H; Lu C; Shao J; Kong D; Wu L; Zheng S
IUBMB Life; 2016 Mar; 68(3):220-31. PubMed ID: 26865509
[TBL] [Abstract][Full Text] [Related]
20. Oligomeric proanthocyanidin derived from grape seeds inhibited NF-κB signaling in activated HSC: Involvement of JNK/ERK MAPK and PI3K/Akt pathways.
Jiang M; Wu YL; Li X; Zhang Y; Xia KL; Cui BW; Lian LH; Nan JX
Biomed Pharmacother; 2017 Sep; 93():674-680. PubMed ID: 28692939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
